| Literature DB >> 35164299 |
Urszula Trych1, Magdalena Buniowska2, Sylwia Skąpska1, Ireneusz Kapusta3, Krystian Marszałek1,3.
Abstract
Blackcurrant juice (Ribes nigrum L.) was subjected to supercritical carbon dioxide (SCCD) at 10, 30, and 60 MPa for 10 min at 45 °C, as well as thermally treated at 45 and 85 °C for 10 min to determine the stability, antioxidant capacity (AC), and bioaccessibility (BAc) of vitamin C, total anthocyanins, and their individual monomers. An in vitro gastrointestinal digestion model completed with dialysis was used to assess BAc. The use of SCCD at each of the pressures applied improved the stability of vitamin C, total anthocyanins, and AC before in vitro digestion. As a result of digestion, the total content of vitamin C, anthocyanins, and AC decreased. The highest BAc of vitamin C was noted in fresh juice (FJ) (40%) and after mild heat treatment at 45 °C (T45) (46%). The highest BAc of total anthocyanins was also noted in the FJ (4.4%). The positive effect of the application of SCCD on the BAc of the delphinidin-3-O-glycosides was observed compared to T45 and thermal pasteurization at 85 °C (T85). Although SCCD did not significantly improve the BAc of vitamin C and total anthocyanins, the higher AC of SCCD samples after intestinal digestion (ABTS+• and DPPH•) and in dialysate (ABTS+•) compared to thermally treated was observed. The protocatechuic acid was detected by UPLC-PDA-MS/MS as the major metabolite formed during the digestion of delphinidin-3-O-rutinoside. This may indicate the influence of SCCD on improvement of the accessibility of antioxidants for digestion, thanks to which more metabolites with high antioxidant activity were released.Entities:
Keywords: anthocyanins; antioxidant activity; bioaccessibility; blackcurrant; in vitro digestion model; supercritical carbon dioxide; vitamin C
Mesh:
Substances:
Year: 2022 PMID: 35164299 PMCID: PMC8839513 DOI: 10.3390/molecules27031036
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.411
Figure 1A schematic diagram showing the work flow described in this study.
l-ascorbic acid (AA), l-dehydroascorbic acid (DHAA) and total vitamin C content at each stage of the digestion of blackcurrant juice.
| Sample | AA (mg/100 mL) | DHAA (mg/100 mL) | Total Vitamin C (AA+DHAA) (mg/100 mL) | |
|---|---|---|---|---|
|
| FJ | 147.71 c ± 11.04 | 2.29 c ± 0.71 | 150.00 c ± 11.08 |
| T45 | 155.09 bc ± 3.56 | 3.17 ab ± 0.91 | 158.25 bc ± 3.14 | |
| T85 | 155.81 bc ± 2.82 | 1.95 c ± 0.65 | 157.76 bc ± 2.60 | |
| SCCD10 | 162.68 ab ± 8.80 | 3.23 ab ± 1.21 | 165.91 ab ± 9.36 | |
| SCCD30 | 156.93 bc ± 5.60 | 3.84 a ± 0.38 | 160.77 bc ± 5.82 | |
| SCCD60 | 169.39 a ± 2.66 | 3.15 ab ± 0.92 | 172.54 a ± 2.25 | |
|
| FJ | 188.72 bc ± 15.05 | 9.10 a ± 1.64 | 197.82 ab ± 16.59 |
| T45 | 201.55 ab ± 11.03 | 1.83 c ± 0.49 | 203.38 ab ± 11.44 | |
| T85 | 180.99 c ± 12.66 | 6.96 b ± 1.56 | 187.95 b ± 13.71 | |
| SCCD10 | 210.91 a ± 4.06 | 2.35 c ± 0.83 | 213.26 a ± 3.66 | |
| SCCD30 | 201.71 ab ± 4.87 | 8.69 ab ± 1.26 | 210.39 a ± 4.95 | |
| SCCD60 | 196.97 abc ± 3.59 | 7.93 ab ± 0.48 | 204.90 ab ± 3.12 | |
|
| FJ | 170.03 a ± 14.71 | 2.73 c ± 0.51 | 172.77 a ± 14.42 |
| T45 | 161.06 ab ± 3.57 | 2.40 c ± 0.77 | 163.46 ab ± 3.73 | |
| T85 | 151.76 b ± 9.45 | 8.19 ab ± 5.27 | 159.96 ab ± 9.56 | |
| SCCD10 | 151.88 b ± 11.08 | 11.65 a ± 2.31 | 163.53 ab ± 9.43 | |
| SCCD30 | 131.45 c ± 12.82 | 4.08 bc ± 1.09 | 135.52 c ± 12.79 | |
| SCCD60 | 152.94 ab ± 5.37 | 1.87 c ± 0.62 | 154.81 b ± 5.49 | |
|
| FJ | 4.25 a ± 0.93 | 13.83 ab ± 2.18 | 18.08 a ± 2.93 |
| T45 | 2.19 bc ± 0.70 | 14.81 a ± 3.15 | 16.99 ab ± 3.67 | |
| T85 | 1.50 cd ± 0.17 | 12.20 ab ± 2.45 | 13.70 bc ± 2.61 | |
| SCCD10 | 2.53 b ± 0.36 | 10.79 b ± 1.72 | 13.32 bc ± 1.36 | |
| SCCD30 | 1.06 de ± 0.36 | 10.94 b ± 1.12 | 12.00 c ± 0.72 | |
| SCCD60 | 0.46 e ± 0.06 | 6.28 c ± 0.67 | 6.74 d ± 0.67 | |
|
| FJ | 42.61 a ± 4.33 | 17.26 b ± 1.69 | 59.87 b ± 5.87 |
| T45 | 33.61 b ± 2.50 | 38.75 a ± 5.30 | 72.37 a ± 3.09 | |
| T85 | 23.04 c ± 1.21 | 20.17 c ± 3.36 | 43.21 c ± 4.14 | |
| SCCD10 | 30.22 b ± 2.89 | 16.04 c ± 1.21 | 46.26 c ± 3.79 | |
| SCCD30 | 21.94 c ± 3.47 | 18.69 c ± 2.21 | 40.63 c ± 1.84 | |
| SCCD60 | 21.43 c ± 1.79 | 23.86 c ± 3.59 | 45.28 c ± 2.52 |
FJ-fresh juice; T45-thermal treated juice at 45 °C; T85-thermal treated juice at 85 °C; SCCD10-juice after supercritical carbon dioxide treatment at 10 MPa; SCCD30-juice after supercritical carbon dioxide treatment at 30 MPa; SCCD60-juice after supercritical carbon dioxide treatment at 60 MPa. The same superscripts letter indicate no significant difference between mean (p ≤ 0.05) in the columns within each digestion stage.
Figure 2Bioaccessibility of total vitamin C in the dialysate after different processing: FJ-fresh juice; T45-thermal treated juice at 45 °C; T85-thermal treated juice at 85 °C; SCCD10-juice after supercritical carbon dioxide treatment at 10 MPa; SCCD30-juice after supercritical carbon dioxide treatment at 30 MPa; SCCD60-juice after supercritical carbon dioxide treatment at 60 MPa (The same letter above the bars indicates no significant difference between the mean (p ≤ 0.05) bioaccessibility of the samples after the different type of treatment).
Total anthocyanin content at each stage of digestion of blackcurrant juice.
| Sample | Df-3 | Df-3 | Cy-3 | Cy-3 | Total Anthocyanins (mg/L) | |
|---|---|---|---|---|---|---|
| control | FJ | 111.13 c ± 5.85 | 371.91 d ± 18.76 | 45.75 c ± 2.18 | 259.66 c ± 12.28 | 788.45 c ± 39.07 |
| T45 | 101.36 c ± 9.04 | 342.26 d ± 30.38 | 41.45 c ± 3.54 | 236.86 c ± 20.05 | 721.93 c ± 62.99 | |
| T85 | 73.62 d ± 4.14 | 236.99 e ± 2.42 | 28.53 d ± 1.94 | 159.28 d ± 2.95 | 498.43 d ± 11.27 | |
| SCCD10 | 138.80 b ± 19.38 | 460.60 c ± 31.44 | 56.08 b ± 7.35 | 306.72 b ± 27.17 | 962.20 b ± 25.31 | |
| SCCD30 | 159.95 a ± 8.23 | 579.44 a ± 34.45 | 71.55 a ± 6.19 | 383.67 a ± 28.74 | 1173.02 a ± 64.69 | |
| SCCD60 | 159.90 a ± 4.85 | 521.73 b ± 11.37 | 62.77 b ± 1.90 | 334.94 b ± 7.45 | 1079.34 a ± 25.30 | |
| oral | FJ | 96.14 a ± 11.09 | 314.95 a ± 19.52 | 34.95 a ± 6.09 | 186.23 a ± 10.10 | 632.28 a ± 45.36 |
| T45 | 85.24 a ± 21.99 | 289.64 a ± 27.35 | 31.98 a ± 2.91 | 162.13 ab ± 18.40 | 568.99 a ± 59.44 | |
| T85 | 44.97 b ± 13.15 | 153.49 b ± 16.45 | 17.25 b ± 5.37 | 105.52 c ± 22.08 | 321.23 b ± 27.05 | |
| SCCD10 | 48.74 b ± 2.42 | 165.39 b ± 6.50 | 18.55 b ± 0.65 | 111.90 c ± 4.34 | 344.58 b ± 13.21 | |
| SCCD30 | 49.97 b ± 8.19 | 150.17 b ± 2.04 | 19.05 b ± 3.26 | 108.77 c ± 10.14 | 327.95 b ± 20.68 | |
| SCCD60 | 56.08 b ± 7.80 | 208.56 b ± 13.46 | 21.12 b ± 2.95 | 132.90 bc ± 9.04 | 418.66 b ± 21.29 | |
| gastric | FJ | 66.37 a ± 6.28 | 237.17 a ± 15.89 | 27.14 a ± 2.56 | 165.86 a ± 6.94 | 496.55 a ± 26.55 |
| T45 | 54.24 c ± 6.95 | 238.86 a ± 13.54 | 22.11 b ± 2.31 | 126.41 c ± 16.47 | 441.62 b ± 26.36 | |
| T85 | 60.33 ab ± 6.08 | 212.41 b ± 10.14 | 21.86 b ± 3.69 | 165.46 a ± 11.30 | 460.05 b ± 19.41 | |
| SCCD10 | 66.57 a ± 1.54 | 228.10 ab ± 4.48 | 25.84 a ± 0.56 | 154.12 ab ± 3.29 | 474.62 ab ± 9.26 | |
| SCCD30 | 62.22 ab ± 1.45 | 213.37 b ± 4.27 | 24.00 ab ± 0.38 | 143.22 b ± 2.57 | 442.82 b ± 8.53 | |
| SCCD60 | 62.56 ab ± 2.98 | 212.83 b ± 7.91 | 23.97 ab ± 0.82 | 142.92 b ± 5.06 | 442.27 b ± 16.64 | |
| intestinal | FJ | 1.88 d ± 0.73 | 11.11 c ± 1.88 | 1.03 b ± 0.31 | 11.53 b ± 1.62 | 25.55 c ± 2.30 |
| T45 | 4.13 a ± 0.49 | 18.59 a ± 1.83 | 2.27 a ± 0.69 | 17.40 a ± 2.55 | 42.39 a ± 5.28 | |
| T85 | 3.17 bc ± 0.31 | 16.11 ab ± 2.67 | 1.91 a ± 0.29 | 15.86 a ± 2.33 | 37.04 ab ± 3.52 | |
| SCCD10 | 3.40 abc ± 0.33 | 16.34 ab ± 1.16 | 2.05 a ± 0.10 | 16.91 a ± 0.62 | 38.69 ab ± 2.04 | |
| SCCD30 | 3.77 ab ± 0.32 | 16.26 ab ± 3.04 | 2.03 a ± 0.26 | 16.78 a ± 1.80 | 38.83 ab ± 4.06 | |
| SCCD60 | 2.80 c ± 0.64 | 12.88 bc ± 2.64 | 1.77 a ± 0.19 | 14.61 ab ± 1.27 | 32.05 bc ± 4.73 | |
| dialysate | FJ | 3.63 a ± 0.79 | 15.72 a ± 0.95 | 1.93 a ± 0.29 | 13.29 a ± 2.11 | 34.56 a ± 3.94 |
| T45 | 1.67 b ± 0.14 | 6.53 c ± 0.91 | 1.28 b ± 0.14 | 9.98 b ± 0.90 | 19.46 b ± 1.63 | |
| T85 | 0.96 b ± 0.16 | 4.03 d ± 0.93 | 1.08 b ± 0.08 | 8.21 bc ± 1.15 | 14.28 c ± 1.21 | |
| SCCD10 | 3.96 a ± 0.83 | 12.51 b ± 2.27 | 1.76 a ± 0.22 | 13.96 a ± 2.59 | 32.19 a ± 5.41 | |
| SCCD30 | 0.94 b ± 0.06 | 4.59 cd ± 0.25 | 1.04 b ± 0.08 | 8.17 bc ± 0.40 | 14.75 bc ± 0.73 | |
| SCCD60 | 0.96 b ± 0.39 | 4.26 d ± 0.18 | 1.19 b ± 0.26 | 6.40 c ± 0.27 | 12.81 c ± 1.04 |
FJ-fresh juice; T45-thermal treated juice at 45 °C; T85-thermal treated juice at 85 °C; SCCD10-juice after supercritical carbon dioxide treatment at 10 MPa; SCCD30-juice after supercritical carbon dioxide treatment at 30 MPa; SCCD60-juice after supercritical carbon dioxide treatment at 60 MPa; df-3-O-glu-delphinidin-3-O-glucoside; df-3-O-rut-delphinidin-3-O-rutinoside; cy-3-O-glu-cyanidin-3-O-glucoside; cy-3-O-rut-cyanidin-3-O-rutinoside. The same superscripts letter indicates no significant difference between the mean (p ≤ 0.05) in the columns within each digestion stage.
Figure 3Bioaccessibility of blackcurrant juice anthocyanins in the dialysate after different processing: FJ-fresh juice; T45-thermal treated juice at 45 °C; T85-thermal treated juice at 85 °C; SCCD10-juice after super critical carbon dioxide at 10 MPa; SCCD30-juice after super critical carbon dioxide at 30 MPa; SCCD60-juice after super critical carbon dioxide at 60 MPa. (The same letter above the bars indicates no significant difference between the mean (p ≤ 0.05) bioaccessibility of the samples after the different type of treatment).
UPLC-PDA-MS/MS properties of delphinidin 3-O-rutinoside and protocatechuic acid as its major detectable metabolite (condition as in p. 3.4.5.2.).
| No. | Compound | RT | [M − H] | Fragment Ions | Absorbance Maxima |
|---|---|---|---|---|---|
| (Min.) | ( | ( | (nm) | ||
| 1 | Delphinidin 3 | 2.71 | 611+ | 303 | 277, 525 |
| 2 | 3,4-Dihydroxybenzoic acid (protocatechuic acid) | 2.14 | 153− | 109 | 260, 294 |
The content of delphinidin-3-O-rutinoside (Df-3-O-rut) and protocatechuic acid at individual stages of the digestion simulation.
| Stage of Digestion | Df-3 | Protocatechuic Acid (µg/mL) |
|---|---|---|
| control | 49.74 ± 0.89 | 0.0 |
| oral | 16.25 ± 1.34 | 0.63 ± 0.02 |
| gastric | 52.66 ± 3.25 | 0.44 ± 0.02 |
| intestinal | 3.65 ± 0.02 | 0.0 |
| dialysate | 0.0 | 0.0 |
Figure 4Antioxidant capacity (AC) of blackcurrant juice determined using the DPPH• assay at each step of digestion after different processing: FJ-fresh juice; T45-thermal treated juice at 45 °C; T85-thermal treated juice at 85 °C; SCCD10-juice after super critical carbon dioxide at 10 MPa; SCCD30-juice after super critical carbon dioxide at 30 MPa; SCCD60-juice after super critical carbon dioxide at 60 MPa. (The same letter above the bars indicates no significant difference between the mean (p ≤ 0.05) within each digestion stage).
Figure 5Antioxidant capacity (AC) using the ABTS+• assay at each step of digestion after different processing: FJ-fresh juice; T45-thermal treated juice at 45 °C; T85-thermal treated juice at 85 °C; SCCD10-juice after super critical carbon dioxide at 10 MPa; SCCD30-juice after super critical carbon dioxide at 30 MPa; SCCD60-juice after super critical carbon dioxide at 60 MPa. (The same letter above the bars indicates no significant difference between the mean (p ≤ 0.05) within each digestion stage).
Figure 6Coefficient of the ratio of increase the antioxidant capacity (AC) in relation to the total anthocyanins content in blackcurrant juice after different processing: FJ-fresh juice; T45-thermal treated juice at 45 °C; T85-thermal treated juice at 85 °C; SCCD10-juice after super critical carbon dioxide at 10 MPa; SCCD30-juice after super critical carbon dioxide at 30 MPa; SCCD60-juice after super critical carbon dioxide at 60 MPa.
Figure 7Proposed pathway for the formation of protocatechuic acid from delphinidin-3-O-rutinoside in the gastrointestinal tract.